T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.

The class IA subgroup of phosphoinositide 3-kinase (PI3K) is activated downstream of antigen receptors, costimulatory molecules, and cytokine receptors on lymphocytes. Targeted deletion of individual genes for class IA regulatory subunits severely impairs the development and function of B cells but not T cells. Here we analyze conditional mutant mice in which thymocytes and T cells lack the major class IA regulatory subunits p85alpha, p55alpha, p50alpha, and p85beta. These cells exhibit nearly complete loss of PI3K signaling downstream of the T-cell receptor (TCR) and CD28. Nevertheless, T-cell development is largely unperturbed, and peripheral T cells show only partial impairments in proliferation and cytokine production in vitro. Both genetic and pharmacologic experiments suggest that class IA PI3K signaling plays a limited role in T-cell proliferation driven by TCR/CD28 clustering. In vivo, class IA-deficient T cells provide reduced help to B cells but show normal ability to mediate antiviral immunity. Together these findings provide definitive evidence that class IA PI3K regulatory subunits are essential for a subset of T-cell functions while challenging the notion that this signaling mechanism is a critical mediator of costimulatory signals downstream of CD28.

[1]  R. Nussbaum,et al.  Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase , 2002, Mammalian Genome.

[2]  K. Okkenhaug,et al.  Cutting Edge: The Phosphoinositide 3-Kinase p110δ Is Critical for the Function of CD4+CD25+Foxp3+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[3]  Michael G. Kharas,et al.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase , 2006, Proceedings of the National Academy of Sciences.

[4]  K. Okkenhaug,et al.  The p110δ Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells1 , 2006, The Journal of Immunology.

[5]  P. Mayinger Faculty Opinions recommendation of A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. , 2006 .

[6]  Robbie Loewith,et al.  A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling , 2006, Cell.

[7]  W. Swat,et al.  Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. , 2006, Blood.

[8]  R. DePinho,et al.  Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy , 2005, Molecular and Cellular Biology.

[9]  F. Natt,et al.  Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  James T. Murray,et al.  hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase* , 2005, Journal of Biological Chemistry.

[11]  E. Vigorito,et al.  Cutting Edge: T Cell Development Requires the Combined Activities of the p110γ and p110δ Catalytic Isoforms of Phosphatidylinositol 3-Kinase1 , 2005, The Journal of Immunology.

[12]  K. Okkenhaug,et al.  Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. , 2005, Blood.

[13]  E. Solary,et al.  Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia , 2005 .

[14]  Antonio Lanzavecchia,et al.  T cell costimulation by chemokine receptors , 2005, Nature Immunology.

[15]  L. Berg,et al.  Cutting Edge: Itk Is Not Essential for CD28 Signaling in Naive T Cells1 , 2005, The Journal of Immunology.

[16]  Sheila M. Thomas,et al.  Role of Phosphoinositide 3-Kinase Regulatory Isoforms in Development and Actin Rearrangement , 2005, Molecular and Cellular Biology.

[17]  A. Trautmann,et al.  Stable Activation of Phosphatidylinositol 3-Kinase in the T Cell Immunological Synapse Stimulates Akt Signaling to FoxO1 Nuclear Exclusion and Cell Growth Control1 , 2005, The Journal of Immunology.

[18]  A. Bilancio,et al.  Signalling by PI3K isoforms: insights from gene-targeted mice. , 2005, Trends in biochemical sciences.

[19]  L. Berg,et al.  Itk is not essential for CD28 signaling in naive T cells. , 2005, Journal of immunology.

[20]  E. Solary,et al.  Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. , 2005, Blood.

[21]  C. Sedwick,et al.  Cutting Edge: CD28-Mediated Transcriptional and Posttranscriptional Regulation of IL-2 Expression Are Controlled through Different Signaling Pathways1 , 2004, The Journal of Immunology.

[22]  M. D. Chamberlain,et al.  The p85α Subunit of Phosphatidylinositol 3′-Kinase Binds to and Stimulates the GTPase Activity of Rab Proteins* , 2004, Journal of Biological Chemistry.

[23]  P. Finan,et al.  Essential role for the p110δ phosphoinositide 3-kinase in the allergic response , 2004, Nature.

[24]  T. Lane,et al.  The CC chemokine ligand 3 regulates CD11c+CD11b+CD8α− dendritic cell maturation and activation following viral infection of the central nervous system: implications for a role in T cell activation , 2004, Virology.

[25]  Sangdun Choi,et al.  Enhanced T Cell Proliferation in Mice Lacking the p85β Subunit of Phosphoinositide 3-Kinase1 , 2004, The Journal of Immunology.

[26]  D. Fruman,et al.  Phosphoinositide 3-kinase: diverse roles in immune cell activation. , 2004, Annual review of immunology.

[27]  P. Finan,et al.  Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. , 2004, Nature.

[28]  D. Metcalfe,et al.  The Phospholipase Cγ1-dependent Pathway of FcϵRI-mediated Mast Cell Activation Is Regulated Independently of Phosphatidylinositol 3-Kinase* , 2003, Journal of Biological Chemistry.

[29]  Mark M Davis,et al.  Continuous T cell receptor signaling required for synapse maintenance and full effector potential , 2003, Nature Immunology.

[30]  Marketa Zvelebil,et al.  Phosphoinositide 3-kinase signalling--which way to target? , 2003, Trends in pharmacological sciences.

[31]  W. Glass,et al.  Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system , 2003, Virology.

[32]  A. Weiss,et al.  The PI‐3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3 , 2003, Immunological reviews.

[33]  A. Hamburger,et al.  The N-Terminal 24 Amino Acids of the p55 Gamma Regulatory Subunit of Phosphoinositide 3-Kinase Binds Rb and Induces Cell Cycle Arrest , 2003, Molecular and Cellular Biology.

[34]  D. Metcalfe,et al.  The phospholipase C gamma 1-dependent pathway of Fc epsilon RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. , 2003, The Journal of biological chemistry.

[35]  J. Ihle,et al.  Essential, Nonredundant Role for the Phosphoinositide 3-Kinase p110δ in Signaling by the B-Cell Receptor Complex , 2002, Molecular and Cellular Biology.

[36]  G. Bismuth,et al.  Imaging antigen-induced PI3K activation in T cells , 2002, Nature Immunology.

[37]  D. Cantrell,et al.  Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse , 2002, Nature Immunology.

[38]  E. Vigorito,et al.  A Crucial Role for the p110δ Subunit of Phosphatidylinositol 3-Kinase in B Cell Development and Activation , 2002, The Journal of experimental medicine.

[39]  T. Asano,et al.  PI3K-mediated negative feedback regulation of IL-12 production in DCs , 2002, Nature Immunology.

[40]  K. Okkenhaug,et al.  Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.

[41]  Tsutomu Takeuchi,et al.  Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice , 2002, Nature Immunology.

[42]  K. Ravichandran,et al.  Regulation of the immune response by SHIP. , 2002, Seminars in immunology.

[43]  H. Kang,et al.  Phosphatidylinositol 3-Kinase p85 Adaptor Function in T-cells , 2002, The Journal of Biological Chemistry.

[44]  W. M. Weaver,et al.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. , 2001, Immunity.

[45]  T. Sasaki,et al.  T cell-specific loss of Pten leads to defects in central and peripheral tolerance. , 2001, Immunity.

[46]  A. Shaw,et al.  Cutting Edge: Distinct Motifs Within CD28 Regulate T Cell Proliferation and Induction of Bcl-XL1 , 2001, The Journal of Immunology.

[47]  K. Okkenhaug,et al.  A point mutation in CD28 distinguishes proliferative signals from survival signals , 2001, Nature Immunology.

[48]  M. Waterfield,et al.  Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.

[49]  A. Weiss,et al.  Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines , 2001, Nature Immunology.

[50]  J. Flores,et al.  Increased phosphoinositide 3‐kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  L. Cantley,et al.  Impaired Kit- but Not FcεRI-initiated Mast Cell Activation in the Absence of Phosphoinositide 3-Kinase p85α Gene Products* , 2000, The Journal of Biological Chemistry.

[52]  L. Cantley,et al.  Impaired kit- but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products. , 2000, The Journal of biological chemistry.

[53]  P. Pandolfi,et al.  Impaired Fas response and autoimmunity in Pten+/- mice. , 1999, Science.

[54]  J. Altman,et al.  Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. , 1999, Journal of immunology.

[55]  R. Nussbaum,et al.  Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-Kinase* , 1999, The Journal of Biological Chemistry.

[56]  F. Alt,et al.  Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.

[57]  Y. Yazaki,et al.  Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. , 1999, Science.

[58]  J. Backer,et al.  Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit , 1998, Molecular and Cellular Biology.

[59]  L. Cantley,et al.  Phosphoinositide kinases. , 1998, Annual review of biochemistry.

[60]  J. Heitman,et al.  Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. , 1997, Biochemical and biophysical research communications.

[61]  J. Imboden,et al.  Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells. , 1997, Journal of immunology.

[62]  D. Jelinek,et al.  A role for phosphatidylinositol 3-kinase in generating T cell help for B cell growth and differentiation. , 1996, Journal of Immunology.

[63]  R. Abraham,et al.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002. , 1996, The EMBO journal.

[64]  D. Jelinek,et al.  Phosphatidylinositol 3-kinase activation in normal human B lymphocytes. , 1996, Journal of immunology.

[65]  F. Homberger [Mouse hepatitis virus]. , 1996, Schweizer Archiv fur Tierheilkunde.

[66]  G. Mills,et al.  CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. , 1995, Journal of immunology.

[67]  J. Marth,et al.  Tissue- and site-specific DNA recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.